The results following the implementation of the Health Information Technology for Economic and Clinical Health (HITECH) Act of 2009 suggest its potential to be a model for other countries to follow when introducing new, valuable technologies.
The results following the implementation of the Health Information Technology for Economic and Clinical Health (HITECH) Act of 2009 suggest its potential to be a model for other countries to follow when introducing new, valuable technologies. HITECH was crafted to increase the adoption of electronic health records (EHRs) to improve the quality and efficiency of care.
A study recently published in Health Affairs analyzed the role of HITECH in the increased prevalence of EHR system adoptions in hospitals through evaluating the efficacy of meaningful-use incentives. Data was collected from the Annual Health Information Technology Supplemental Survey of the American Hospital Association in 2008 to 2015, which was sent to CEOs at every hospital in the United States.
“We hypothesized that system-affiliated, private for-profit, small, rural, and nonteaching hospitals would respond more strongly to meaningful-use incentives,” the researchers wrote.
The survey results revealed 4269 eligible hospitals and assessed the quality of computerized functions based on the type of EHR the hospital used, while considering hospital characteristics and demographics.
Prior to the implementation of meaningful use incentives, EHR adoption rates grew by an average of 3.2% annually for eligible hospitals. In the period after implementation, the average annual increase reached 14.2%. However, it’s important to note that even hospitals that weren’t eligible for incentives improved their rate of adoption during this time—before implementation the rate of annual increase among ineligible hospitals was 0.1%, and 3.3% following the incentives.
“Even though the large observed increase in EHR adoption among eligible hospitals after meaningful-use incentives were introduced is compelling evidence of HITECH’s effectiveness, it is possible that many hospitals would have adopted EHRs without the policy intervention,” the authors noted. “By using ineligible hospitals as a control group, we found that HITECH can be credited with increasing the rate of EHR adoption by 8 percentage points per year.”
These results establish HITECH’s influence in producing gains in EHR adoption for hospitals. Although the study acknowledged that EHR adoption was likely occur in hospitals’ long-term plans, the authors accredited HITECH with implementing incentives that caused hospitals to prioritize the adoption.
“Given the complexity of large-scale change in hospitals, this result is dramatic and suggests that HITECH can serve as a model for other countries seeking to increase EHR adoption among hospitals and for other policy efforts seeking to promote technology adoption more generally,” the authors concluded.
Emily Goldberg Shares Insights as a Genetic Counselor for Breast Cancer Risk Screening
October 30th 2023On this episode of Managed Care Cast, Emily Goldberg, MS, CGC, a genetic counselor at JScreen, breaks down how genetic screening for breast cancer works and why it is so important to increase awareness and education around these screening tools available to patients who may be at risk for cancer.
Listen
Provisional CDC data show that US babies gained roughly a year in life expectancy in 2022; study findings indicate that the COVID-19 pandemic significantly raised the risk of preterm birth for expectant California mothers; New York Attorney General Letitia James said about 4 million New Yorkers were affected by a data breach of the medical transcription company Perry Johnson & Associates.
Read More
Examining Telehealth Uptake to Increase Equitable Care Access
January 26th 2023To mark the publication of The American Journal of Managed Care®’s 12th annual health IT issue, on this episode of Managed Care Cast, we speak with Christopher M. Whaley, PhD, health care economist at the RAND Corporation, who focuses on health economics issues, including the influence of the COVID-19 pandemic on health care delivery.
Listen
Researchers Identify Potential Biomarkers for SMA Motor Improvement Following Nusinersen Treatment
November 17th 2023A retrospective, exploratory analysis identifies biomarkers predictive of spinal muscular atrophy (SMA) response to nusinersen and suggests the efficacy of using machine learning algorithms to anticipate patient outcomes.
Read More